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The Biochemical Laboratory at Cambridge is the place where Marjory Stephenson 
established microbiology as a biochemical science and demonstrated that bacteria were 
useful as experimental material quite apart from their disease-producing action. It is also 
the place where in the early 1950s Professor Milton R. J. Salton, at that time a graduate 
student of Professor Ernest Gale, initiated biochemical investigations of bacterial cell 
walls. Marjory Stephenson died too early (1948) to witness this remarkable event but one 
can guess the wonder she would have expressed for the enzymes involved in the synthesis 
of the wall peptidoglycan, a structure which contains muramic acid and several D-amino 
acids and is unique to the bacterial world. Perhaps she would have found these enzymes 
even more extraordinary than those concerned with the utilization of molecular hydrogen 
and with the oxidation and reduction of inorganic substrates, about which she wrote in 
1939 ‘all the enzymes found in the animal will ultimately turn up in some bacterium or 
other whilst these found only in bacteria will be far more numerous’ (Stephenson, 1939). A 
few years later, appraising the progress made in bacterial metabolism, Marjory Stephenson, 
who was always fascinated by the life of the organisms, noted with enthusiasm: ‘information 
is now being rapidly gained on the course of the biochemical process leading to cell synthesis 
. . .We seem, in fact, to be witnessing a transition from katabolic to anabolic studies, made 
possible only by the use of the microbe as experimental material’ (Stephenson, 1949). 
Among the new sources responsible for this fresh stream of knowledge were studies of the 
intracellular changes resulting from chemotherapeutic agents, antibiotics and other cell 
poisons. We all know how crucial for the bacterial cell are the various steps by which the 
wall peptidoglycan precursors are synthesized in the cytoplasm and are assembled into a 
rigid, net-like polymer outside the plasma membrane. We also know how essential for the 
unravelling of the mechanisms involved was the use of D-CyClOSerine, bacitracin and 
penicillin. 
The decision of the Society to pay tribute to Marjory Stephenson by organizing a lecture 
on the biosynthesis of the bacterial cell wall peptidoglycan and on the mode of action of 
penicillin, therefore seems to be most appropriate. However, as I stand before you on this 
occasion, I do so with mixed feelings. I am deeply honoured by the invitation but I am also 
convinced that friends who have much contributed to these problems, deserve this honour 
more than I do and would fulfil the duty in a more elegant way. Moreover, I have been 
fortunate in having extremely able colleagues : Milina Leyh-Bouille and Jacques Coyette 
who were with me from the start of our work; Jean-Marie Frkre, Jean Dusart and Martine 
Nguyen-Distkche who later joined us with fresh ideas; Harold R. Perkins now in Liverpool, 
Manuel Nieto now in Madrid, Peter E. Reynolds from Cambridge, and Jerry J. Pollock 
now in Stony Brook all played important, sometimes decisive roles in the work. I am sad 
that we cannot share this moment together. 
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Fig. I .  Wall peptidoglycan synthesis. ( I )  Elongation of a nascent peptidoglycan strand on the 
plasma membrane. (2) Transpeptidation between two nascent peptidoglycan strands leading to 
crosslinking and release of D-Ala. (3) Hydrolysis by DD-carboxypeptidase action leading to release 
of D-Ala without formation of a peptide bond. G,  N-Acetylglucosamine; M, N-acetylmuramic acid. 
Penicillin: the ideal chemotherapeutic agent ? 
In 1965, in the same issue of the Proceedings of the National Academy of Sciences, Wise & 
Park and Tipper & Strominger proposed, independently, that penicillin blocked the 
biosynthesis of the bacterial wall peptidoglycan by preventing the closure of the peptide 
bridges between adjacent strands. The reaction inhibited was a transpeptidation as a result 
of which, under normal conditions of growth, the carboxyl group of the penultimate 
D-alanine residue of the pentapeptide donor ending in D-Ala-D-Ala was transferred to the free 
o-amino group of another peptide acceptor (Fig. I) with the result that new peptide bonds 
were formed, equivalent amounts of D-Ala were released from the peptide donors and the 
newly made peptidoglycan became insoluble. Tipper & Strominger suggested a possible 
mechanism for the transpeptidation reaction and for its inhibition by penicillin. In the 
absence of the antibiotic, the C-terminal D-Ala-D-Ala of a pentapeptide donor would first 
react with the transpeptidase to form an acylenzyme intermediate with the release of D-Ala 
and, subsequently, the amino end of the peptide acceptor would react with this intermediate 
to form the cross-bridge. The proposed model was a Ping-Pong Bi Bi mechanism : 
R-D-Ala-D-Ala + Enzyme -+ R-D-Ala-Enzyme + D-Ala 
R-D-Ala-Enzyme + NH2-R’+ R-D- Ala-NH-R’ + Enzyme 
Penicillin, assumed to be a close structural andogue of the C-terminal D-Ala-D-Ala, would 
react with the donor binding site on the transpeptidase, yielding an irreversible, inactive 
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penicilloyl-enzyme complex. Penicillin had a high selective toxicity because it was postu- 
lated to act on one enzyme which occurred solely in bacteria and because the initial driving 
force for the interaction was due to the presence in the enzyme of a penicillin-binding site 
which normally recognized a C-terminal D- Ala-D- Ala sequence, a structural feature com- 
pletely missing in eukaryotic cells. Penicillin was very efficient because of the irreversible 
nature of the bond formed between the drug and the enzyme. Of the antimicrobial agents 
known, penicillin was the one which best fulfilled the canons of chemotherapy (at least if 
one does not take into account the allergic reactions associated with it and its destruction 
by penicillinase action). The hypothesis remains, but investigations carried out along dif- 
ferent lines in various laboratories in the last 12 years do not substantiate it in all its details 
and the precise molecular mechanism by which p-lactams exert their lethal effect remains 
elusive. 
The multiple enzymes concerned with the wall peptidoglycan crosslinking 
As early as 1966, it was known that the system involved in peptide crosslinking contained 
more than one single enzyme and that it consisted of at least two antagonistic activities 
(Araki et al., 1966; Izaki, Matsuhashi & Strominger, 1966). In addition to the transpeptidase 
activity which catalyses peptide bond formation, bacteria also contain a DD-carboxypepti- 
dase activity which simply hydrolyses the C-terminal D-Ala-D-Ala sequences of pentapeptide 
units without performing any transfer reaction (Fig. I) .  As the transpeptidase is sensitive 
to penicillin, so too is the DD-carboxypeptidase activity. The idea immediately brought 
forward was that the DD-carboxypeptidase activity was there to limit the number of penta- 
peptide units made available to the transpeptidase activity and, therefore, to control the 
extent of peptidoglycan crosslinking. It was also suggested that the DD-carboxypeptidase 
might be an uncoupled transpeptidase. Roughly the idea was correct. Yet, it was far from 
expressing the real complexity of the problem. 
The concept of a ‘nascent peptidoglycan’, which was rather vague in 1965, was rigorously 
substantiated thanks to the elegant studies of Ward & Perkins (1973). In Bacillus licheni- 
formis, chains consisting of multiple disaccharide-peptide units were shown to grow by 
addition of the new units at the reducing terminus of the lengthening chain. In the process, 
the reducing terminal N-acetylmuramic acid of the growing chain is transferred from its link 
with the membrane to the non-reducing N-acetylglucosamine terminus of the new disac- 
charide-peptide unit which is itself linked to the membrane (Fig. I). The membrane accep- 
tor on which the new disaccharide-peptide units are made is the undecaprenyl phosphate 
carrier. However, the membrane acceptor on which polymerization of the nascent peptido- 
glycan chains occurs has not yet been definitely characterized. 
When growing in liquid suspensions, protoplasts excrete the soluble, nascent peptidogly- 
can they make and new walls cannot be formed. However, when incubated on the surface 
of an agar medium of low fluidity, protoplasts of B. lichenijiormis were shown to be 
able to revert successfully to normal rod-shaped bacilli (Elliott et dl., 1975a, b). Hence, 
insolubilization of the peptidoglycan by peptide crosslinking between nascent strands can 
be carried out by cells which at the onset of the process completely lack pre-existing walls 
(Fig. I). The same process probably takes place in normal, wall-containing cells. In this 
case, however, insolubilization of the nascent peptidoglycan is mainly achieved by attach- 
ment to the pre-existing wall peptidoglycan. Attachment of part of the precursor can be 
carried out by transglycosylation at the level of the glycan strands, a reaction which is not 
sensitive to penicillin (Mirelman, Bracha & Sharon, 1972, 1974), but transpeptidation at 
the level of the peptide units appears to be the major mechanism involved. Two alternatives 
may exist: the nascent peptidoglycan may act as carboxyl donor through its C-terminal 
D-Ala-D-Ala sequences while the pre-existing wall peptidoglycan would act as amino 
acceptor; conversely, D-Ala-D-Ala sequences in the pre-existing wall peptidoglycan may 
function as donors, and amino groups of the newly synthesized peptidoglycan strands would 
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function as acceptors. In fact, the transpeptidation reaction can proceed in either direction. 
The first mechanism occurs in B. licheniforinis (where it may prevail; Ward & Perkins, 1974) 
(Fig. 2) and the second in Gafkya homari (Hammes, 1976; Hammes & Kandler, 1976) 
(Fig. 3). This latter mechanism is especially complex. Indeed, those peptide units of the 
nascent peptidoglycan which serve as acceptor groups for transpeptidation are tetrapep- 
tides resulting from prior DD-carboxypeptidase action. However, pentapeptide units must 
remain present in this nascent peptidoglycan in such a way that through the active trans- 
peptidation of the tetrapeptide units, these pentapeptide units are passively incorporated 
into the wall peptidoglycan where they can serve as donor units for further expansion of the 
polymer. In vivo, the newly synthesized peptidoglycan strands which undergo attachment 
probably contain equimolar amounts of pentapeptide and tetrapeptide units. Such a ratio 
would allow a maximum degree of crosslinking of 50 % and oligomers larger than dimers 
could not be formed. In fact, such structural features are those found in the wall peptido- 
glycan of G. homari. 
In parallel to the different mechanisms of wall peptidoglycan expansion, the specific 
inhibition of the DD-carboxypeptidase activity in B. subtilis and B. stearothermophilus does 
not cause detectable damage to the cell (Blumberg & Strominger, 1971; Yocum, Blumberg 
& Strominger, 1974), suggesting that the transpeptidase is the enzyme that is physiologically 
important. On the contrary, the specific inhibition of the DD-carboxypeptidase activity in 
G. homari is sufficient to prevent peptidoglycan incorporation and to cause cessation of cell 
growth (Hammes, 1976). Hence, a unified view on the nature of the enzyme on which 
penicillin binding causes cessation of cell growth (and cell lysis) cannot be proposed. The 
concept of a penicillin ‘killing site’ may well escape a precise definition. 
In the Gram-negative bacteria and in various Gram-positive bacilli, the interpeptide bond 
made by transpeptidation is a D-Ala-(D)-meso-diaminopimelic acid linkage in cc position to a 
free carboxyl group (Fig. I), a structural feature which fits well the substrate requirements 
for DD-carboxypeptidase action. Hence the extent of peptidoglycan crosslinking is sus- 
ceptible to regulation not only by DD-carboxypeptidase action on the pentapeptide units 
before incorporation of the nascent peptidoglycan but also by DD-carboxypeptidase action 
on the interpeptide bonds in the completed peptidoglycan. DD-Carboxypeptidases which 
perform such endopeptidase activity exist ; they are also sensitive to penicillin (Bogdanovsky, 
Bricas & DezblCe, 1969). 
Septum formation in Escherichia coli has received much attention. A bold and attractive 
working hypothesis made by Mirelman, Yashow-Gan & Schwarz (1976) is that the nascent 
peptidoglycan would act as carboxyl donor for transpeptidation reactions with two types of 
acceptors. Reaction with the pre-existing wall peptidoglycan would lead to wall elongation, 
whereas reaction with a modified nascent peptidoglycan previously deprived of donor 
sites by DD-carboxypeptidase action and accumulated at the equator of the cell (i.e. where 
it is synthesized) would lead to septum formation. The specific inhibition of the DD-carboxy- 
peptidase responsible for the destruction of the donor sites of the nascent peptidoglycan 
(and for its accumulation) and for the specific inhibition of the transpeptidase which uses 
this modified nascent polymer as amino acceptor would therefore prevent cell septation 
and would cause cell filamentation, a morphological damage which can be induced in E. coli 
cells by low levels of ampicillin. In fact, fractionation of the membrane-bound peptide cross- 
linking enzyme system of E. coli has shown that the DD-carboxypeptidase-transpeptidase- 
endopeptidase activities occur in two distinct forms, one of them being sensitive to low 
levels of ampicillin (and perhaps involved in cell septation) and the other being sensitive to 
much higher levels of ampicillin (and perhaps involved in cell elongation) (Pollock et al., 
1974; Nguyen-Distkche et al., 1g74a, b). 
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Fig. 2 .  Attachment of a nascent peptidoglycan strand (open symbols) to the pre-existing wall 
peptidoglycan (black symbols) in Bacillus lichenfornzis, The nascent peptidoglycan acts as carboxyl 
donor (A = D-Ala-D-Ala) and the pre-existing wall peptidoglycan acts as amino acceptor (-H). 
( I )  Transpeptidase action ; (2 )  DD-carboxypeptidase action. Prior DD-carboxypeptidase action on 
the nascent peptidoglycan prevents further transpeptidation. 
A 
H 
Fig. 3. Attachment of a nascent peptidoglycan strand (open symbols) to the pre-existing wall 
peptidoglycan (black symbols) in Gaflkya homari. The pre-existing wall peptidoglycan acts as 
carboxyl donor (f = D-Ala-D-Na) and tetrapeptide units of the nascent peptidoglycan act as 
amino acceptors (-€I). ( I )  DD-Carboxypeptidase action ; ( 2 )  transpeptidase action. Prior DD-CarbOXy- 
peptidase action on the nascent peptidoglycan is required for further transpeptidation. 
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The penicillin-binding components 
Tremendous efforts are being made in order to study the penicillin-binding components 
from penicillin-sensitive cells on the assumption that penicillin-sensitive enzymes and 
penicillin-binding proteins are synonymous. These studies, initiated in Professor Strornin- 
ger’s laboratory, yielded important results (for a review, see Blumberg & Strominger, I 974). 
In agreement with the known complexity of the peptidoglycan crosslinking enzyme system, 
multiple penicillin-binding sites exist in both Gram-positive and Gram-negative bacteria. 
These binding sites occur in the plasma membrane and, to all appearances, they are distinct 
proteins. They can be detected by dodecylsulphate-polyacrylamide slab gel electrophoresis 
of membranes to which radioactive penicillin has been bound; they are numbered in the 
order of decreasing molecular weight. This technique has revealed the presence of at least 
six penicillin-binding proteins in E. coli, five in B. subtilis and B. rnegaterium, four in B. 
stearothermophilus and three in B. cereus. 
Two complementary approaches have been taken. One, which has been more especially 
applied to E. coli, is to try to relate one or several of the penicillin-binding components to 
the various morphological responses that p-lactams can elicit in this organism: inhibition 
of cell septation and cell division; bulge formation ; formation of osmotically-stable ovoid 
cells; cessation of cell growth and cell lysis (Spratt, 1975, 1977). The six main penicillin- 
binding proteins in E. coli are minor components of the plasma membrane. If one assumes 
that one penicillin-binding site occurs per molecule, then one cell contains about 230 
molecules of protein I (mol. wt 91 OOO), 20 of protein 2 (mol. wt 66000), 50 of protein 3 
(mol. wt ~OOOO), I I O of protein 4 (rnol. wt ~ ~ o o o ) ,  1800 of protein 5 (mol. wt. 42000) and 
570 of protein 6 (mol. wt 40000). Proteins 4, 5, and 6 are probably not involved in the 
effects on cell morphology produced by p-lactams. Protein 2 is required for the growth of 
E. coli as a rod-shaped cell and is the protein on which the amidinopenicillanic acids act to 
produce ovoid cells. Binding of p-lactams to protein 3 seems to cause inhibition of cell 
division and filamentation. Binding to both proteins 2 and 3 seems to cause bulge forma- 
tion. Protein I would then be the site at which p-lactams bind to inhibit cell elongation, to 
cause cessation of cell growth and to induce cell lysis, i.e. protein I would be the ‘main’ 
transpeptidase. Protein I, however, may be two proteins, a situation which makes the prob- 
lem more complex. Furthermore, in Salmonella typhimurium, protein 4, and not protein I ,  
appears to have the greatest capacity for carrying out transpeptidation in vitro (Shepherd, 
Chase & Reynolds, 1977). Finally, inhibition of cell elongation and cessation of growth 
may be caused by the inhibition of a penicillin-sensitive enzyme which cannot be detected 
as a penicillin-binding protein. Thus, for example, the penicillin-sensitive DD-carboxypepti- 
dase IB  of E. coli apparently cannot be detected by this technique (Tamura, Imae & Strom- 
inger, I 976). Hence, the penicillin-binding components detected by autoradiography of the 
slab gels do not necessarily reflect the complexity of the peptidoglycan crosslinking enzyme 
complex. Conversely, the efficiency of the binding largely depends upon the experimental 
conditions (antibiotic concentration, time of exposure etc.) and, under certain circum- 
stances, penicillin may react non-specifically with proteins - in the sense that they are not 
members of the enzyme complex - which consequently are revealed as penicillin-binding 
components. 
A second approach is to isolate and characterize the penicillin-binding components 
(Blumberg & Strominger, 1974). Protein 5 of B. subtilis is a DD-carboxypeptidase. I t  was 
isolated by affinity chromatography on 6-aminopenicillanic acid-substituted Sepharose of 
solubilized membranes previously treated with cephalothin under conditions which allowed 
saturation of compounds I to 4 but not of compound 5. Protein 3 of B. stearothermophilus 
(Yocum et al., 1974) and proteins 5 and 6 of E. coli are also DD-carboxypeptidases (Spratt 
& Strominger, 1976). 
Obviously, the full significance of the penicillin-binding sites cannot be understood as 
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long as the relationship between them and the multiple penicillin-sensitive enzymes is not 
clearly established. One of the difficulties of the problem is the following. DD-Carboxypepti- 
dase activity can be easily estimated by measuring the C-terminal D-Ala residue released 
from the relevant UDP-N-acetylmuramyl-pentapeptide precursors. Parallel to this, at least 
until recently, the penicillin-binding sites to which an enzyme activity could be assigned were 
DD-carboxypeptidases. The test for transpeptidase activity as it is performed in many labora- 
tories makes use of various particular cell-free systems containing both the pre-formed wall 
peptidoglycan and all the enzymes involved in the synthetic pathway beyond the level of the 
nucleotide precursors. In the presence of the exogenously added nucleotides, the reaction 
proceeds through the complex series of steps and culminates in peptidoglycan crosslinking. 
Of course, such an assay is of no value for testing a transpeptidase separated from the 
bacterial envelope and disconnected from the other enzymes which precede the trans- 
peptidation reaction. The difficulty, however, can be overcome. 
Exocellular enzymes from Streptomyces ~6 I and Actinomadura ~ 3 9  as models 
for the study of the peptidoglycan crosslinking enzyme system 
When a natural phenomenon is complex, it is useful to set up an artificial, well-defined 
model which mimics it as closely as possible. Such a model could be devised using enzymes 
from some actinomycetes, in particular Streptomyces R ~ I  and Actinomadura ~39. During 
growth these strains excrete exocellular enzymes able to catalyse reactions which resemble 
those catalysed in vivo by the corresponding crosslinking enzyme systems. Each of these 
enzymes consists of one single polypeptide chain with a molecular weight of 38000 for the 
R ~ I  enzyme and 53000 for the R39 enzyme. Many of their physicochemical and enzymic 
properties are described in two recent reviews where details and a complete list of references 
can be found (Ghuysen, 1977; Frbe  et al., 1976b). Each of these enzymes performs three 
activities : a DD-carboxypeptidase activity, a transpeptidase activity and a penicillin-degrad- 
ing activity. What, in summary, did we learn from them? 
DD-Carboxypeptidase-transpeptidase activity 
( I )  Both enzymes catalyse hydrolysis reactions ; they are DD-carboxypeptidases. The 
C-terminal sequence giving the highest activity is D-Ala-D-Ala but the preceding L-amino 
acid residue also has a considerable effect on enzyme activity. Although differences exist 
between the two enzymes with regard to the influences of charged groups at the end of the 
side-chain of this L-amino acid residue, the synthetic tripeptide Ac2-L-Lys-D-Ala-D-Ala is 
an excellent substrate for each of them. The standard reaction is 
Ac,-L-Lys-D-Ala-D-Ala + H20 -+ D- Ala + Ac,-L-Lys-D- Ala 
( 2 )  Both enzymes are also transpeptidases. They catalyse transpeptidation reactions 
between the above tripeptide acting as donor and certain peptides acting as acceptors. In 
order to function as acceptor, the amino group must belong to a structure resembling that 
found in the natural peptide acceptor involved in the in vivo transpeptidation. The trans- 




-D-Ala-D-Ala peptide units 
A2pm 
where the acceptor group is the N-terminal glycine residue. Of the peptides that function 
as acceptors for the R ~ I  enzyme, the most effective are those with an N-terminal glycine, 
and-Gly-Gly is one of the best. The standard reaction catalysed by the R ~ I  enzyme is 
A~~-~-Lys-~-Ala-o-Ala  + Gly-Gly -+ D- Ala + A~~-~-Lys-~-Ala-Gly-Gly 
20 J. M. GHUYSEN 
The transpeptidation reaction in Actinomadura ~ 3 9  occurs between 
L- Ala-D-aGln 
I 




where the acceptor is the amino group located on a D-carbon (of meso-diaminopimelic acid) 
in a position to a free carboxyl group. The basic requirement of the R39 enzyme for an 
acceptor is precisely such a structural feature. Hence, the R39 enzyme is unable to catalyse 
transpeptidation reactions leading to the synthesis of peptide bonds in an endo-position 
and therefore it differs strikingly from the R ~ I  enzyme. The standard reaction catalysed by 
the ~ 3 9  enzyme is 




(3) Whenever the enzyme performs transpeptidation, concomitant hydrolysis of the pep- 
tide donor also occurs. D-Ala is thus released by two pathways : by hydrolysis (DD-carboxy- 
peptidase activity) and by transpeptidation (transpeptidase activity), the two processes 
competing with each other. 
In aqueous media, at neutral pH and at low acceptor concentrations, both enzymes act 
mainly as DD-carboxypeptidases ; their transfer activities are low. However, the proportions 
of the catalytic activity that can be channelled into the hydrolysis and transpeptidation path- 
ways, respectively, greatly depend upon the environmental conditions. Replacement of 
part of the water of the reaction mixture by solvents of low polarity preferentially de- 
creases the DD-carboxypeptidase activity so that transpeptidation may largely supersede 
hydrolysis. Transpeptidation is also favoured by raising the pH value of the reaction mixture. 
The m-carboxypeptidase activity of the ~ 3 9  enzyme is little affected by the ionic strength 
but its transpeptidase activity is specifically enhanced at high ionic strength. The R ~ I  
enzyme, however, has maximal hydrolytic and transfer activities at low ionic strength. 
Finally, peptide acceptors behave as non-competitive inhibitors of the hydrolysis pathway 
and therefore high acceptor concentrations favour transpeptidation. 
(4) With the ~ 3 9  enzyme and at low donor concentrations, hydrolysis is inhibited by 
increasing concentrations of acceptor to a greater extent than transpeptidation is increased. 
The acceptor is an inhibitor of the total enzyme activity. However, at high peptide donor 
concentrations when the donor site of the enzyme is saturated, the increase in the rate of the 
transfer reaction and the decrease in the rate of hydrolysis caused by increasing concentra- 
tions of acceptor (at least within certain limits) are commensurate. The enzyme activity that 
is diverted from the hydrolysis pathway because of the presence of the acceptor is channelled 
entirely into the transfer pathway. Under these conditions, the acceptor is an inhibitor of 
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hydrolysis but not of the total enzyme activity which remains constant. Finally, another 
interesting feature of the system is that when complex peptide acceptors are used, not only 
hydrolysis but transpeptidation itself may be inhibited by excess acceptor. 
(5 )  The effects that the concentrations of the donor and the acceptor, respectively, exert 
on the rates of transfer and hydrolysis reactions concomitantly catalysed by the R ~ I  enzyme 
suggest that these reactions proceed through an ordered mechanism in which the acceptor 
binds first to the enzyme (A, acceptor; D, donor; E, enzyme): 
+ D  
E . A d  E.A.D---+ Transfer 
+ H20'\& + D  
E . H 2 0  --+ E. H 2 0  . D 4 Hydrolysis 
The results obtained are not compatible with a mechanism where the donor binds first to 
the enzyme as in the Ping-Pong Bi Bi mechanism suggested by Tipper & Strominger (I  965). 
For complex peptide acceptors which at  high concentrations inhibit the transpeptidation 
pathway, an additional acceptor binding site would be present on the enzyme leading to 
the formation of an (enzyme-acceptor2-donor) complex which would be non-productive 
for transpeptidation, and to the formation of an (enzyme-H20-acceptor-donor) complex 
remaining productive for hydrolysis. The above scheme would then b modified : 
E . A h  E.A.D-----+ Transfer 
+D 
+i)/ J r  E.A2.D 
E' 
-1 H2O \ \\ + D  L E . H,O - E . H,O . D d Hydrolysis 
E . H,O . A .  D --+ Hydrolysis J r  
(6) Both R ~ I  and ~ 3 9  enzymes can catalyse transpeptidation reactions in which the same 
peptide serves as donor and acceptor, thus leading to the formation of peptide dimers and, 
sometimes, peptide trimers. The tetrapeptide Ac-L-Lys-D-Ala-D-Ala can be regarded as a 





peptide moiety of the peptidoglycan precursor in Streptomyces R6 I .  Ac-L-Lys-D-Ala-D-Ala 
is utilized by the R ~ I  enzyme in media of low polaritywith the result thatW(D-Ala-Gly)-L-Lys 
bonds are formed. The reaction products are D-Ala, the tripeptide monomer 
Ac-L-Ly s-D-Ala, the heptapeptide dimer 
GlY A 
_J 
Ac-L- Ly s-D- Ala-D- Ala, 
GlY 
Ac-L-Ly s-D- Ala-Gly _I 
1 GlY 
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the hexapeptide dimer (i.e. the former dimer lacking the C-terminal D-Ala) and a mixture 
of nona- and decapeptide trimers 
Ac-L-Lys-D-Ala-(D-Ala) 
Ac-L-Ly s-D-Ala-Gl y i 
Ac-L-Ly s-D- Ala- Gly _I 
GlY J 
Similarly, in media of high ionic strength, the R39 enzyme utilizes the pentapeptide 
L-Ala-D-Glu 
L(~)-meso-A2prn-(~)-~-Ala-~-Ala 




and a mixture of octa- and nonapeptide dimers 
L- Ala-D-Glu 
L- Ala-D- Glu 
I L :' A2Pm 





Increased yields of peptide dimer are obtained by providing the ~ 3 9  enzyme with the above 
pentapeptide at a concentration ( 3 0 0 , ~ ~ )  which saturates the peptide donor site of the 
enzyme but is too low to induce its own dimer formation, and a high concentration (60 mM) 





(which lacks the C-terminal D-Ala-D-Ala sequence and thus functions only as acceptor). 
Under these conditions, the rate of formation of the mono-amidated peptide dimer 
L- Ala-D-ccGln 
-D-A!a 
L- Ala-D-Glu A2pm 
A*Pm 
L
i L - D - A l a -  D 
I 
D 
is twofold higher than the rate of hydrolysis of the pentapeptide into 
L- Ala-D-Glu 
(L)-meso-A,pm-(L)-D-Ala 
Note that the above peptide dimers made by the action of the ~ 3 9  enzyme are either 
identical or extremely similar to those present in the Gram-negative bacteria, in many 
bacilli and in Actinoniadura R39 itself. 
Penicillin-degrading activity 
(I) Like various ,8-lactamases, acylases and esterases, both the R ~ I  and ~3gZenzymes 
degrade p-lactams. The reaction, however, is peculiar in two respects. One peculiarity 
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Fig. 4. Enzymic fragmentation of benzylpenicillin (I) into phenylacetylglycine (11) and N-formyl-D- 
penicill amine (111). 
During prolonged incubation, the released N-formyl-D-penicillamine undergoes spontaneous 
dimerization into di-(N-formyl-D-penicillamine) disulphide. The mechanism of the catalysis remains 
to be discovered. In particular, one should mention that fragmentation of benzylpenicillin by the 
DD-carboxypeptidase of B. sfearothermuphilus also yields phenylacetylglycine (Hammarstrom & 
Strominger, I 975). 5,5,-Dimethyl-A2-thiazoline carboxylic acid would be the other fragment 
(Hammarstrom & Strominger, 1976). However, the fragment arising from the thiazolidine moiety of 
penicillin was almost certainly mischaracterized since under the conditions prevailing during the 
reaction (55 min; 55 "C; pH 6.5), 5,5-dimethyl-A2-thiazoline carboxylic acid has a half-life of 130 s 
and is transformed into N-formyl-D-penicillamine (J. M. Frkre, unpublished data). Under these 
conditions, the mechanism proposed for the enzymic fragmentation of penicillin on the assumption 
that 5,5-dimethyl-A2-thiazoline carboxylic acid was one of the primary products released remains 
entirely hypothetical. 
concerns the nature of the degradation products. Benzylpenicillin is degraded into phenyl- 
acetylglycine and N-formyl-D-penicillamine with the formyl substituent arising from C5 of 
benzylpenicillin (Fig. 4). When phenoxymethylpenicillin is used instead of benzylpenicillin, 
phenoxyacetylglycine and N-formql-~-penicillamine are produced. Hence the nature of the 
acyl substituent does not modify the pathway of the reaction. The overall reaction involves 
the addition of two H,O molecules and results in the hydrolysis of the amide bond and in 
the rupture of both C5-C6 and C5-S linkages. Enzyme reactivation and fragmentation of 
the penicillin molecule are concomitant events. However, N-formyl-D-penicillamine may 
not be the initial fragment arising from the thiazolidine moiety of the penicillin molecule 
but the nature of the possible intermediate remains to be determined. The products result- 
ing from the interaction with cephalosporins have not yet been established. It is certain, 
however, that these antibiotics are also irreversibly destroyed during the reaction. h o t h e r  
peculiarity of the reaction is that it is a slow or a very slow process. Depending upon the 
enzymes and the P-lactams, the kcat values for the reactions range from 0.28 x I O - ~  to 
1-4 x I O - ~  s-l (Table I). For the purposes of comparison, the kcat values for the hydrolysis 
of Ac,-L-Lys-D-Ala-D-Ala into D-Ala and Ac,-L-Lys-D-Ala by the R ~ I  and ~ 3 9  enzymes are 
about 55 and 17-5 s-l, respectively. 
( 2 )  The main feature of the reaction is that it proceeds through (i) the formation of a 
rather stable, stoicheiometric enzyme-P-lactam complex EI* in which the enzyme (E) is 
inactivated and the P-lactam (I, for inhibitor) is chemically modified, and (ii) the subsequent 
breakdown of complex EI* with regeneration of the enzyme and release of the antibiotic 
as biologically inactive metabolites 
k f o m t i o n  kbreakdown 
E+I  ~ -+ EI* ----+ E + degradation products 
Formation of complex EI* is characterized by a second order rate constant (kforWtlon in 
























































































































































































































































































































































































































































































































































































The Thirteenth Marjory Stephenson Memorial Lecture 25 
complex formation could be analysed by fast kinetics techniques. The simplest model 
which best explains the data is 
K k3 k, or 
E + I + E I h E I * - - -  -+ E + degradation products 
Enzyme and p-lactam first react to form a complex EI (characterized by a dissociation con- 
stant K, in M) which, in turn, isomerizes into complex EI*. The isomerization step is charac- 
terized by a first order rate constant k3 (in s-l). Of course, k4 and kbredkdown are synonymous 
and the k,/K ratio (in M-I s-l) is equal to kfomation. Table I gives the kformation (with, in 
some cases, the individual K and k, values) and the kbreakdown values for various enzyme- 
/i’-lactam systems. The kbreakdown values have been converted into the half-lives of the 
complexes EI* : these range for 80 to 40000 min. The degradation of the complexes El* is 
thus the rate-limiting step and the kbreskdown values are equivalent to the kcat values for the 
overall reaction : antibiotic --+ degradation products. 
(3) In the strict sense, one could claim that p-lactams are substrates of the R ~ I  and ~ 3 9  
enzymes. However, by immobilizing the enzymes in the form of inactive complexes El*, 
at least for some time, they also behave as inhibitors. The lower the K value, the higher the 
k, value (i.e. the higher the krormtion) and the higher the k4 value, the better is the anti- 
biotic as a substrate. Conversely, the lower the K value, the higher the k, value (i.e. the 
higher the kformation) but the lower the k ,  value, the more active is the antibiotic as an 
inhibitor. At a low [I] value such that [I] < K ,  the important parameter is the kformation 
or k3/K value since the rate of formation of complex EI* directly depends on it. At a very 
low [I] value, the k, value is also very important since, at the steady state, the smaller its 
value, the higher is the proportion of the total enzyme that is immobilized in the form of 
complex EI*. The effectiveness of a p-lactam as an inhibitor can be expressed by the K,  
value, 
E 
which is equivalent to the Henri-Michaelis constant for the reaction p-lactam + degradation 
products. If, as is the case with the exocellular enzymes, k4 < k,, then 
Obviously, the lower the Kf value, the more active is the p-lactam as an inhibitor. The 
effectiveness of the inhibitor, however, is expressed more accurately by 
which gives the fraction of enzyme which remains functional at the steady state. Thus for 
[I] s- k4K/k, and at  the steady state, all the enzyme is immobilized in the form of complex 
EI* irrespective of the absolute k4 value. At [I] = k4K/k3 if both k4 and k3 values are very 
small, then the formation of complex EI* may be so slow that within the duration of the 
experiment, it may not occur at all, i.e. the enzyme remains active. 
(4) In no case is the recognition of the antibiotic by the enzyme, as expressed by the K 
value, exceedingly good (Table I) but there is a 20000-fold variation between the highest 
and the lowest k, values. Values of 180 and 13 s-l for the k3 constant are similar to the kcat 
value of a true enzymic reaction. Although slow, breakdown of the complexes EI* is 
enzymic at least in the sense that active groups in the enzyme and/or a proper configuration 
of the protein are involved in the process. Thus boiling of the complex EI* made between 
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Table 2. Relation between the rates of formation of complexes M* with the exocellular 




Benzylpenicillin 7‘3 2.8 2.6 
Carbenicillin 3.6 4 0.9 
Cephalosporin C 31 9 3‘4 
Ampicillin 626 867 0.7 
Cephalogl ycine 3523 I 150 3’1 
benzylpenicillin and the R ~ I  enzyme stabilizes it (and makes it sensitive to pronase and 
thermolysine). Serine is the residue involved in penicillin binding to the ~ 6 1  enzyme (Fr6l-e 
et al., 1 9 7 6 ~ ) .  Another example is given by the ~ 3 9  enzyme. Breakdown of the complex 
formed between this latter enzyme and benzylpenicillin yields phenylacetylglycine (and 
probably N-formyl-D-penicillamine) when breakdown occurs in a medium of high ionic 
strength under which conditions the enzyme is reactivated. At low ionic strength (where 
the R39 enzyme is not stable), enzyme reactivation does not occur and breakdown of the 
complex yields benzylpenicilloic acid. Hence, under certain conditions, the enzyme behaves 
although with a low efficiency, as a classical penicillinase. 
(5) It had been known for several years that the R39 enzyme was more sensitive to 
p-lactams than the R ~ I  enzyme. Table I gives the antibiotic concentrations required to inhibit 
enzyme activity by 50 % (ID5, values). With all the ,8-lactams tested, the kformation values 
are always higher with the R39 enzyme than with the R ~ I  enzyme, and the k b r & d o m  
values are always lower with the ~ 3 9  enzyme than with the R ~ I  enzyme. Necessarily, the 
R ~ I  enzyme is more resistant than the ~ 3 9  enzyme. The ktormation value, however, is the 
important parameter (at least under the conditions where the ID,, values were determined) 
as shown by the fact that for each antibiotic, the ratio of kformatjon (f r the ~ 3 9  enzyme) to 
kformation (f r the R ~ I  enzyme) is very similar to the ratio of ID,, (for the R ~ I  enzyme) to 
IDbo (for the ~ 3 9  enzyme) (Table 2). 
(6) The differences between the R ~ I  and ~ 3 9  enzymes with respect to their action on the 
p-lactams leads to a new concept of penicillin resistance. They show that alterations in the 
structure and/or the conformation of the enzymes that result in increased kbreakdom values 
(without altering the kformation value) or in decreased kformation values (without altering the 
kbr&dom value) lead to ‘intrinsic resistance’. The comparison between the R ~ I  and ~ 3 9  
enzymes also provides an explanation for the large differences in penicillin sensitivity 
exhibited by the enzymes of the peptide crosslinking system. 
(7) The concomitant interaction between enzyme, peptide donor Acz-L-Lys-D-Ala-o-Ala 
and p-lactam was studied both on the basis of the effect of the P-lactam on the rate of 
hydrolysis of the peptide donor and on the basis of the effect of the peptide donor on the 
rate of formation of complex EI*. Kinetically, the interaction was competitive but the 
conclusions were that it was not possible to decide whether or not binding of peptide donor 
and penicillin to the enzymes was mutually exclusive, and that a structural analogy between 
penicillin and peptide donor could not be justified on the basis of such experiments. It is 
clear that binding of penicillin to its site on the R ~ I  and R39 enzymes with formation of 
the complexes EI* induces conformational changes in the enzymes. These changes might 
be sufficiently pronounced to freeze them in confcrmations that prevent both DD-carboxy- 
peptidase and transpeptidase activities. Other techniques are being used in order to solve 
this important problem. 
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The cell-bound peptidoglycan crosslinking enzyme system 
in Streptomyces R ~ I  
The exocellular R ~ I  enzyme is ‘lost’ in the culture medium. The question therefore arises 
whether the model derived from the exocellular enzymes for the various reactions concerned 
with peptide donor, peptide acceptor and P-lactam applies to the physiological, cell-bound 
peptidoglycan crosslinking enzyme system. 
The composition and functioning of the crosslinking enzyme system in Streptomyces 
are not yet fully understood. Recent progress has been made and I am indebted to Drs 
Mklina Leyh-Bouille, Martine Nguyen-Distcche and J. Dusart, and to Dr P. E. Reynolds 
from the University of Cambridge, for results that have not yet been published elsewhere. 
What do we know of the system? 
(I)  The tripeptide Ac,-~-Lys-~-Ala-~-Ala is both hydrolysed and utilized in a transfer 
reaction with Gly-Gly by at least two types of cell-bound enzyme activities. The two activi- 
ties are located in distinct parts of the cell envelope and are antagonists in the sense that one 
of them acts mainly as a DD-carboxypeptidase and is highly sensitive to penicillin whereas 
the other acts mainly as a transpeptidase and has a low sensitivity to penicillin. 
(2) The enzyme which acts mainly as a DD-carboxypeptidase (with a low transpeptidase 
activity, at least in water, at neutral pH and at low acceptor concentrations) and has a high 
sensitivity to penicillin is released from the mycelium during transformation into proto- 
plasts in sucrose medium (unpublished data). This lysozyme-releasable enzyme is very 
similar, perhaps identical, to the exocellular enzyme : the proportion of total activity that is 
channelled into hydrolysis and transfer depends upon the environmental conditions; the 
enzyme utilizes the tetrapeptide Ac-L-Lys-D-Ala-D-Ala with formation of peptide dimer ; 
when treated with [14C]benzylpenicillin and submitted to SDS slab gel electrophoresis, it 
migrates exactly as the exocellular enzyme ; finally, its activities are inhibited by antibodies 
prepared against the exocellular enzyme. Its exact localization in the cell is not known, but 
the comparison between the levels of exocellular and lysozyme-releasable enzymes among 
various streptomycetes suggests that a correlation exists between the amount of enzyme 
that is excreted in the medium and the amount of lysozyme-releasable enzyme present in the 
mycelium. Streptomyces rimosus, for example, contains extremely low levels of lysozyme- 
releasable enzyme and excretes only traces of exocellular enzyme. 
(3) The enzyme which acts mainly as a transpeptidase (with a low DD-carboxypeptidase 
activity) and has a low sensitivity to penicillin is firmly associated with the plasma membrane. 
Gly-Gly, various peptides possessing an N-terminal glycine residue and other amino 
compounds are utilized by the isolated membranes for transpeptidation reactions with 
Ac,-L-Lys-D-Ala-D-Ala as donor. Qualitatively, the specificity profile of the membrane- 
bound enzyme fits well the requirements for amino acceptor exhibited by the exocellular 
enzyme (Dusart et al., 1973). There is an exception, however: Ac-L-Lys-D-Ala-D-Ala is 
not utilized as substrate by the isolated membranes (unpublished data). The kinetics of the 
membrane-catalysed transpeptidation between Ac,-~-Lys-~-Ala-~-Ala and Gly-Gly fit 
the general initial rate equation for an enzyme-catalysed bimolecular reaction 
J GlY 
GlY _I 
(S,+S, 2 s;+s;): 
where a0 is equal to the reciprocal of the maximal rate, and and @, are related to the 
Michaelis constants by @,/O0 = Kml and @,/(Do = Kmz (unpublished data). One astonishing 
property of the isolated membranes is their ability to perform transpeptidation reactions 
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Table 3. Interaction between p-luctam and the membrane-bound 
transpeptidase of Streptomyces ~ 6 1  
1 0 5  x , Half-life of 
hormation kbrcakdown complex EI" 
at 37 "Ct at 37 "C$ at 37 "C$ Ki?' EXCl.&o$ LDS0%i IDso$ 
Antibiotic (M-' S-l) (S-') (mid (PM) (PM) (PM) (PM)  
330 3.5 I 0  9 5 8 
41 2 4 5 18 
Benzylpenicillin 50 I 1  I04 2'2 3 5 2 
Carbenicillin 15 7'3 160 5 30 33 34 
Cloxacillin 13 12.3 94 I 0  45 50 39 
Cephalosporin C 5 330 3.5 660 220 I I 2  540 
400 28 
Ampicillin 
Phenoxymethylpenicillin 14  
t Unpublished data. 
$ From Marquet et a/. (1974); half-life, Excl.D6,, LD,, and ID,, values for P-lactarns other than those 
8 Concentration which gives 50 % inhibition of the ability of conidia to form single cell colonies. 
listed above can be found in Marquet et al. (1974). 
in a solid, frozen state. A temperature as low as - 30 "C is required to prevent the enzyme 
from catalysing the reaction, suggesting that the enzyme functions in a lipid environment 
that remains remarkably fluid at low temperature (Dusart et al., 1975). 
(4) The isolated membranes fix in a rather stable manner about 25 pmol [14C]benxyl- 
penicillin per mg protein, under which conditions the transpeptidase activity is totally 
inhibited (Marquet et ul., 1974). The interaction between the membrane transpeptidase and 
p-lactams fits the general scheme (Marquet et al., 1974) 
kformation kbreakdown 
E +I ------+ EI* ------+ E + degradation products 
During breakdown, the transpeptidase is reactivated and recovers its initial ability to react 
with penicillin. With [14C]benzylpenicillin, release of the radioactivity and enzyme recovery 
proceed with the same kbreakdom value of 1.1 x 1 0 ~ ~  s-' (indicating a half-life value of 104 
min) (Marquet et al., 1974). A major part of the released radioactivity occurs in the form of 
[14C]benzylpenicilloic acid (about 75 %) and a minor part of it in the form of another 
metabolite X (about 25 %; unpublished data). Hence, it seems safe to conclude that (i) the 
transpeptidase in the membrane reacts with p-lactams according to the model proposed for 
the exocellular enzyme, (ii) it functions as a penicillinase with 'a low kcat value and (iii) at 
least most of the penicillin-binding sites on the membrane are the transpeptidase molecules. 
(5) Table 3 gives the kfomtion and kbreakdom values for the interaction between 
p-lactams and the membrane-bound transpeptidase (unpublished data). These determinations 
were possible because the isolated membranes of Streptomyces R ~ I  do not possess any 
classical' penicillinase activity. Penicillinase activity would degrade penicillin into penicil- 
laic acid at a much faster rate than transpeptidase activity is regenerated through breakdown 
of complex EL*. In fact, membrane-bound and exocellular penicillinase activities occur in 
many streptomycetes other than strain ~ 6 1 .  On the basis of the Ki values of Tables I and 
3, the membrane-bound transpeptidase is less sensitive to P-lactams than the exocellular 
enzyme. Thus the Ki values for benzylpenicillin are 10 n M  with the exocellular enzyme and 
2-2 p~ with the membrane-bound enzyme. With all the P-lactams tested, except for ampi- 
cillin, the kfomtion is always higher with the exocellular enzyme than with the membrane- 
bound enzyme (Tables I and 3). 
(6) The data of Table 3 also show that the effectiveness of p-lactams is very similar with 
regard to their ability to inhibit the membrane-bound transpeptidase (K, and ID,, values), 
to bind to isolated membranes (as shown by competition; Excl . D5, values) and to inhibit 
the formation of single cell colonies from conidia on agar nutrient plates (LD50 values). 
Hence one (or the) enzyme which has to be inactivated in order to prevent the early develop- 
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ment of the mycelium from the spores appears to be the membrane-bound transpeptidase. 
It may be that the lysozyme-releasable enzyme is not present at that early stage of cell 
growth. If present, then, because of its high penicillin sensitivity, it may simply immobilize 
a certain amount of p-lactam (detoxication effect). The present results, however, do not 
exclude the possibility that the lysozyme-releasable enzyme is, in turn, physiologically 
important at later stages of the mycelial growth. This question is currently under investiga- 
tion. 
(7) Antibodies specific for the R ~ I  exocellular enzyme do not bind to the isolated mem- 
branes and have no effects on its transpeptidase activity (unpublished data). The enzyme 
might be buried too deeply within the lipid phase of the membrane to be accessible. How- 
ever, analysis on SDS slab gels of the membranes previously charged with radioactive benzyl- 
penicillin reveals two to three penicillin-binding components of molecular weight of about 
20000 to 25 000, in addition to another penicillin-binding component of molecular weight 
of about 50 000 (unpublished data). These components have molecular weights that are 
either considerably lower or higher than the molecular weights of the lysozyme-releasable 
and exocellular enzymes. Extraction of the membranes (or of the washed mycelium) with 
the cationic detergent N-cetyl-N,N,N-trimethylammonium bromide, folIowed by fiftration 
on Sephadex G-100, yields a soluble preparation (Dusart et al., 1975) enriched in enzyme 
activity. The enzyme thus solubilized remains a transpeptidase with low DD-carboxypepti- 
dase activity but its properties are somewhat altered with the results that (i) it has a better 
fit for the two synthetic substrates Ac,-L-Lys-D-Ala-D-Ala and Gly-Gly (as revealed by the 
QD and @A values), (ii) both the kfomtion and kbreakdown values for the interactions with 
p-lactams are modified and (iii) [14C]benzylpenicillin is now fragmented with formation of 
[14C]phenylacetylglycine as observed with the exocellular enzyme (unpublished data). 
(8) The relationship between the membrane-bound transpeptidase and both the lysozyme- 
releasable and exocellular enzymes in Streptomyces ~6 I is still rather mysterious. However, 
an interesting observation was made with Streptornyces K I ~  (unpublished data). Like 
strain ~ 6 1 ,  Streptomyces K I  5 excretes an exocellular DD-carboxypeptidase, contains a 
lysozyme-releasable DD-carboxypeptidase and has a transpeptidase fixed on its membrane. 
The two former enzymes - but not the membrane-bound transpeptidase - are sensitive to 
the anti-exocellular R ~ I  enzyme antibodies. Streptomyces K I  5,  in addition, possesses on its 
membrane a DD-carboxypeptidase able to perform low transpeptidase activity. This mem- 
brane-bound DD-carboxypeptidase which is hardly detectable in Streptomyces ~6 I, has, in 
Streptomyces ~ 1 5 ,  the following properties: (i) it is inhibited by the anti-exocellular R ~ I  
enzyme antibodies; (ii) after extraction with the cationic detergent and on the basis of its 
elution pattern on Sephadex G-100, it has a molecular weight higher than that of the mem- 
brane-bound transpeptidase; and (iii) it enables the isolated membranes to react with 
Ac-L-Lys-D-Ala-D-Ala. It is therefore tempting to postulate that in Streptomyces K I  5, the 
membrane-bound DD-carboxypeptidase is at the branching point of two distinct pathways : 
one leading via the lysozyme-releasable enzyme to enzyme excretion, and the other leading 
somehow to a membrane-bound transpeptidase in the form of iso-enzymes responsible 
for the presence of multiple penicillin-binding sites in the membrane. One may also postu- 
late that the same situation occurs in all streptomycetes but that, depending upon the strain 
and/or the stage during cell growth, great variations in the amounts of enzymes present 
may occur with the result that some of them may be beyond the limits of detection. The 
membrane-bound transpeptidase, however, is always detectable. 
GlY J 
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Table 4. Interaction between @-lactams and the membrane-bound DD-curboxypeptidase 









105 x Half-life of Growth 
kformstion kbrwkdown complex EI" inhibition 
at 37 "C at 37 "C at 37 "C in m.i.c. 
560 I 0  130 0.18 I 
445 4'4 263 0'10 2 
2 30 1'5 820 0.07 I 0  
I 9  3'7 310 2 25 
4'5 24 50 60 25 
0.75 6 205 80 50 
1.85 6.5 183 35 250 
(M-l S-l) (s-l) ( d n )  Ki (PM) 
-/- From Coyette eta[ .  (1g77b). 
6ookcnv Pen G 
Carbe 
Oxa Cloxa Methi 
1 A /- 
10 20 30 40 50 250 
M.i.c. ( p ~ )  
Fig. 5 .  Relationship between the m.i.c. values for Streptococcusfaecaliand the second order krormation 
values for the formation of the membrane-bound ~~-carboxypeptidase-~-lactam complexes. 
Pen V, phenoxymethylpenicillin ; Pen G, benzylpenicillin; Amp, ampicillin ; Oxa, oxacillin ; Carbe, 
carbenicillin; Cloxa, cloxacillin; Methi, methicillin. 
The membrane- bound Dmcarboxypep t idase in Strep tococcus faecalis 
ATCC9790 as the target of ,8-lactams 
Bacteria, more conventional as sources of biochemical material than streptomycetes, 
were also investigated. Streptococcus faecalis provides another example where a relation- 
ship exists between the effects of P-lactams on bacterial growth and their activity in vitro 
upon one defined cell-bound enzyme. In the present case, the enzyme is a membrane-bound 
DD-carboxypeptidase active on Ac,-L-Lys-D-Ala-D-Ala and able to catalyse exchange 
reactions with simple amino compounds such as D-Ala, Gly and Gly-Gly (Coyette et al., 
I 974, 1977~2, b). The isolated membranes of Streptococcus faecaZis contain six penicillin- 
binding proteins which altogether fix about IOO pmol benzylpenicillin per mg protein (R. 
Fontana, unpublished data). The DD-carboxypeptidase is protein 6 and it represents about 
one-third of all the binding sites. The kfonnation and kbreakdown values for the interaction 
between the membrane-bound DD-carboxypeptidase and p-lactams are given in Table 4. 
Interaction with benzylpenicillin yields phenylacetylglycine and N-formyl-D-penicillamine. 
Fragmentation is prevented by heating the membrane-penicillin complex at IOO "C. All 
the complexes tested have half-lives which are equal to or longer than the generation time 
of the organism (30 min). Finally, the relative effectiveness of the P-lactams in vivo rests 
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almost entirely upon the kformation values: as shown by the data of Table 4 and Fig. 5,  the 
higher the kfomation value the lower is the minimum inhibitory concentration (m.i.c.) of the 
corresponding P-lactam. Thus, in Streptococcus jaecalis, normal functioning of the mem- 
brane-bound DD-carboxypeptidase enzyme may be important if not necessary for cell 
growth. 
The DD-carboxypeptidase of the unstable spheroplast of Proteus mirabilis 
Mention should be made of enzymes which may well form ternary complexes with peptide 
donor and P-lactam. One of them is the membrane-bound DD-carboxypeptidase isolated 
from spheroplasts of the unstable L-form of Proteus mirabilis strain 19 (Martin, Maskos & 
Burger, 1975; Martin, Schilf & Maskos, 1976; Schilf et al., 1977). Its interaction with 
benzylpenicillin is characterized by a kf,rm:Lt,on of about 4000 M - ~  s-l (W. Schilf & J-M. Fr&re, 
unpublished data) and a khreakdown f about 3-3 x I O - ~  s-l, i.e. a half-life of about 3 min (at 
37 "C). Benzylpenicilloic acid is released. Of course, such a rapid breakdown confers a high 
penicillin resistance to the enzyme. The Proteus bacterial form possesses the equivalent of the 
L-form DD-carboxypeptidase and, in addition, a second DD-carboxypeptidase characterized 
by amuch higher penicillin sensitivity and a half-life of several hours for the complex EI* with 
benzylpenicillin (H. H. Martin, personal communication). Protein 5 of E. coli (Spratt, 1977) 
and protein 5 of Salmonella typhimurium (Shepherd et al., 1977) are other examples of enzymes 
forming complexes EI* with benzylpenicillin which have very short half-lives (5  min). 
Another interesting feature of the Proteus L-form enzyme is that, kinetically, it is 
inhibited by penicillin in a non-competitive manner. Competitive kinetics are never 
persuasive because a ternary complex may be formed only at higher concentrations of either 
the substrate or penicillin than those which are, or can be, used. Conversely, non-competitive 
kinetics indicate with some weight that binding of donor substrate and binding of penicillin 
occur on at least partially independent sites on the enzyme. 
Conclusions 
The use of artificial substrates in uncoupled transpeptidation assays can probably be 
extended to all bacteria. At present, its application has been limited, presumably because it is 
difficult to design a proper system of donor and acceptor. However, dimerization of the 
pentapeptide L-Ala-D-Glu is achieved not only by the 
i(L)-meso-A,pm-( L)-D-Ala-D-Ala 
exocellular enzyme of Actinomadura R39, but also by various membrane-bound transpepti- 
dases, such as those of E. coli (Nguyen-Disthche et al., 1g74a, b)  and Salmonella typhimurium 
(Shepherd et al., 1977). In fact, the penicillin-binding proteins r ,  4 and 5 of Salmonella 
typhimzirium are DD-carboxypeptidases-transpeptidases able to catalyse dimer formation 
(Shepherd et al., 1977). That the same reaction can be catalysed by enzymes originating 
from organisms taxonomically very different is not surprising when the wall peptidoglycans 
in these organisms have the same primary structure. 
There are reports in the literature where enzymes are designated as transpeptidases on the 
basis of their ability to replace the C-terminal D-Ala residue of a peptide donor by Gly or a 
simple D-amino acid residue. Such an exchange reaction does not prove the occurrence in 
the enzyme of an 'acceptor site' concerned with peptide dimerization. This lack of accuracy 
in the terminology is unfortunate since it adds confusion to the picture. 
The present review has been necessarily limited to selected topics. However, from an 
integration of these and other studies, it has become certain that the mode of action initially 
proposed for penicillin in order to explain its effect on the exocellular R ~ I  and ~ 3 9  enzymes 
is general. Quantitatively, the constants involved vary considerably depending upon the 
enzymes and their bacterial origin and, qualitatively, there is more than one possible path- 
way for the enzymic degradation or fragmentation of the antibiotic molecule. 
3 M I  C IOI 
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The concept of chemotherapy, which stems back to the discovery of Prontosil in 1935, 
was firmly established by the first cures achieved by penicillin in 1941. A second penicillin era, 
which we are still living in, started in 1957 when it was learnt that semi-synthetic penicillins 
with increased penicillinase resistance could be made by adding side-chains to the 6-amino- 
penicillanic acid nucleus. This revolution was ‘to open the possibility of chemotherapy 
being able to adapt itself by producing new products to meet the adaptations nature 
produces in the micro-organisms’ (Wilson, 1976). One day, the peptidoglycan crosslinking 
enzyme system may be so precisely known that specific inhibitors will be built on a rational 
basis and used as new antibacterial agents. It is difficult to predict when biochemists will 
open this third revolution. It is certain that the problem is being fiercely attacked from 
several quarters. 
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